Health Canada has expanded its approval of Abbvie’s oral therapy Maviret (glecaprevir/pibrentasvir), making it the first eight-week, pan-genotypic treatment available for both acute and…
ALAGILLE SYNDROME
News
Health Canada has expanded its approval of Abbvie’s oral therapy Maviret (glecaprevir/pibrentasvir), making it the first eight-week, pan-genotypic treatment available for both acute and…
CHOLANGITIS
NewsLiver transplant may help prevent bile duct cancer in people with primary sclerosing cholangitis (PSC) who have advanced bile duct dysplasia, a serious…
Discussion
FATTY LIVER DISEASE
ColumnsHumans tend to love animals — especially the fuzzy, cuddly kind. I’m no exception. Anyone who knows me knows my devotion to my three cats:…
Don't have an account?
|
Already have an account?
Create your account by filling in the information below:
By creating an account, you are agreeing to the Privacy Policy and Terms of Service.